XML 61 R38.htm IDEA: XBRL DOCUMENT
v3.22.0.1

Contractual Agreements (Details Narrative) - USD ($) |  |  |  |  | 3 Months Ended | 12 Months Ended
--- | --- | --- | --- | --- | --- | ---
Jan. 01, 2026 | Jan. 01, 2025 | Oct. 14, 2021 | Mar. 29, 2012 | Dec. 31, 2020 | Dec. 31, 2021 | Dec. 31, 2020
Malpractice Insurance [Line Items] |  |  |  |  |  |  |
Revenue from Contract with Customer, Excluding Assessed Tax |  |  |  |  | $ 0 |  |
Contract research and development expenses |  |  |  |  |  | $ 4,900,000 | $ 6,800,000
Collaborative Arrangement [Member] | Abbott Products Inc [Member] |  |  |  |  |  |  |
Malpractice Insurance [Line Items] |  |  |  |  |  |  |
Percentage of net sales |  |  |  | 1.00% |  |  |
Royalties, commitment amount |  |  |  | $ 1,000,000.0 |  |  |
Percentage of royalties reduction based upon product launch |  |  |  | 50.00% |  |  |
License Agreement [Member] |  |  |  |  |  |  |
Malpractice Insurance [Line Items] |  |  |  |  |  |  |
License fee |  |  | $ 11,000,000.0 |  |  |  |
Percentage of royalty payment |  |  | 20.00% |  |  |  |
Revenue from Contract with Customer, Excluding Assessed Tax |  |  |  |  |  | $ 16,100,000 | $ 0
License Agreement [Member] | Maximum [Member] |  |  |  |  |  |  |
Malpractice Insurance [Line Items] |  |  |  |  |  |  |
Sales milestone |  |  | $ 160,000,000.0 |  |  |  |
License Agreement [Member] | Subsequent Event [Member] | Forecast [Member] |  |  |  |  |  |  |
Malpractice Insurance [Line Items] |  |  |  |  |  |  |
Potential license fees from a licensee | $ 5,000,000.0 | $ 5,000,000.0 |  |  |  |  |
License Agreement [Member] | TLANDO XR [Member] |  |  |  |  |  |  |
Malpractice Insurance [Line Items] |  |  |  |  |  |  |
License fee |  |  | 4,000,000.0 |  |  |  |
Clinical and development milestones |  |  | $ 35,000,000.0 |  |  |  |

X
- Definition Clinical and development milestones. + References No definition available. + Details
Name: | lpcn_ClinicalAndDevelopmentMilestones
Namespace Prefix: | lpcn_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Percentage of net sales + References No definition available. + Details
Name: | lpcn_CollaborativeArrangementRoyaltiesPercentageOfNetSales
Namespace Prefix: | lpcn_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition License fee. + References No definition available. + Details
Name: | lpcn_LicenseFee
Namespace Prefix: | lpcn_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Percentage of royalties reduction based upon product launch. + References No definition available. + Details
Name: | lpcn_PercentageOfRoyaltiesReductionBasedUponProductLaunch
Namespace Prefix: | lpcn_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percentage of royalty payment. + References No definition available. + Details
Name: | lpcn_PercentageOfRoyaltyPayment
Namespace Prefix: | lpcn_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Potential license fees from a licensee. + References No definition available. + Details
Name: | lpcn_PotentialLicenseFeesFromALicensee
Namespace Prefix: | lpcn_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Sales milestone revenue recognized. + References No definition available. + Details
Name: | lpcn_SalesMilestoneRevenueRecognized
Namespace Prefix: | lpcn_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_MalpracticeInsuranceLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 730 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373 + Details
Name: | us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 4 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 924 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 11.L) -URI http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856 + Details
Name: | us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The amount the entity has committed to make for future royalty guarantees. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 928 -SubTopic 440 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6473578&loc=d3e63223-108013 + Details
Name: | us-gaap_RoyaltyGuaranteesCommitmentsAmount
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=lpcn_AbbottProductsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=lpcn_LicenseAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementScenarioAxis=srt_ScenarioForecastMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=lpcn_TLANDOXRMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |